federal_register: 2022-25002
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-25002 | Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada; Public Meeting; Request for Comments | Notice | The Food and Drug Administration (FDA, the Agency, or we) is hosting a virtual public meeting entitled "Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada." The purpose of the public meeting is to obtain public input on a draft amended environmental assessment (EA) prepared by FDA in support of an approved new animal drug application (NADA 141-454) concerning AquAdvantage Salmon (AAS), in response to an order by the U.S. District Court, Northern District of California. | 2022-11-17 | 2022 | 11 | https://www.federalregister.gov/documents/2022/11/17/2022-25002/draft-amended-environmental-assessment-for-production-of-aquadvantage-salmon-at-the-bay-fortune-and | https://www.govinfo.gov/content/pkg/FR-2022-11-17/pdf/2022-25002.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA, the Agency, or we) is hosting a virtual public meeting entitled "Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island,... |